PMID- 11866839 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 1469-0691 (Electronic) IS - 1198-743X (Linking) VI - 2 IP - 3 DP - 1996 Feb TI - Novel human herpesviruses (human herpesviruses 6, 7 and 8). PG - 159-167 AB - The number of members in the family Herpesviridae has increased in the last 10 years due to the description of three novel human herpesviruses: human herpesvirus 6 (HHV-6) in 1986, human herpesvirus 7 (HHV-7) in 1990, and human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), in 1994. HHV-6 and HHV-7 were first isolated from blood lymphocyte cultures, while HHV-8 was identified following a specific molecular biology approach in the search for the etiologic agent of Kaposi's sarcoma. The three viruses are lymphotropic, T-cells being the targets of HHV-6 and HHV-7, and B-cells being probably those of HHV-8. The ability to be propagated in cell cultures in vitro differs according to the virus concerned: this can be done readily with HHV-6, with more difficulties in the case of HHV-7, and has not yet been achieved in the case of HHV-8. Human infection with HHV-6 and HHV-7 is ubiquitous, widespread and acquired early in life. HHV-8 epidemiology is still unclear, and there are two hypotheses: a restricted dissemination in the general population like herpes simplex virus type 2, or a widespread infection like all other human herpesviruses. The polymerase chain reaction is the common method for the detection of infection using specific primers and probes for HHV-6, HHV-7 and HHV-8 respectively. Serologic assays are only available for HHV-6 and HHV-7, with limitations being due, in particular, to possible cross-reactions with cytomegalovirus. HHV-6 is the causative agent of exanthem subitum (sixth disease). Its role as an opportunistic agent and immune dysfunction inducer is debated and currently under investigation. The pathogenic role of HHV-7 seems to be modest, with one case of exanthem subitum reported so far. HHV-8 is strongly associated with three diseases: Kaposi's sarcoma, Castleman's disease and body-cavity-based lymphomas. The therapy against these novel viruses has to be considered in the future. FAU - Agut, Henri AU - Agut H AD - Virology Laboratory, CNRS EP57, CERVI, Pitie-Salpetriere Hospital, and. FAU - Dupin, Nicolas AU - Dupin N FAU - Aubin, Jean-Thierry AU - Aubin JT FAU - Calvez, Vincent AU - Calvez V LA - eng PT - Journal Article PL - England TA - Clin Microbiol Infect JT - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases JID - 9516420 EDAT- 1996/02/01 00:00 MHDA- 2002/02/28 10:00 CRDT- 1996/02/01 00:00 PHST- 1996/02/01 00:00 [pubmed] PHST- 2002/02/28 10:00 [medline] PHST- 1996/02/01 00:00 [entrez] AID - S1198-743X(14)65138-7 [pii] AID - 10.1016/s1198-743x(14)65138-7 [doi] PST - ppublish SO - Clin Microbiol Infect. 1996 Feb;2(3):159-167. doi: 10.1016/s1198-743x(14)65138-7.